Results

Total Results: 222 records

Showing results for "disorder".

  1. srdr.ahrq.gov/projects/1324/studies/175795
    January 01, 2015 - Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder … Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder … Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder
  2. srdr.ahrq.gov/projects/1671/studies/196094
    nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  3. srdr.ahrq.gov/projects/1671/studies/196095
    January 01, 1991 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  4. srdr.ahrq.gov/projects/1671/studies/196092
    January 01, 2002 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  5. srdr.ahrq.gov/projects/1671/studies/196084
    January 01, 2007 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  6. srdr.ahrq.gov/projects/1671/studies/196097
    January 01, 2006 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  7. srdr.ahrq.gov/projects/1671/studies/196085
    January 01, 1994 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  8. srdr.ahrq.gov/projects/1671/studies/196087
    January 01, 2017 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  9. srdr.ahrq.gov/projects/1671/studies/196086
    January 01, 1998 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
  10. srdr.ahrq.gov/projects/1165/studies/186940
    January 01, 2017 - psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder … psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder
  11. srdr.ahrq.gov/projects/1565/studies/189298
    January 01, 2014 - Longitudinal assessment of sleep disordered breathing in Vietnam veterans with post-traumatic stress disorder … Longitudinal assessment of sleep disordered breathing in Vietnam veterans with post-traumatic stress disorder … Exclusion criteria h/o psych disorder
  12. srdr.ahrq.gov/projects/1671/studies/196402
    January 01, 2016 - Reset Cancel Study Preview Study Title and Description Network meta-analysis of migraine disorder … Information Comments ( 0 ) | Post/View Title Data Title Network meta-analysis of migraine disorder
  13. srdr.ahrq.gov/projects/1671/studies/196136
    January 01, 2013 - Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder … Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder
  14. srdr.ahrq.gov/projects/1324
    January 01, 2021 - Morgans A., Carlson-Bremer D., Andrews J. 2016 Management and Outcomes of Binge-Eating Disorder … Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder … Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder … McBroom AJ1, Lallinger KR1, Sanders-Schmidler GD1. 2017 Attention Deficit Hyperactivity Disorder … 2018 Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder
  15. srdr.ahrq.gov/projects/1634/studies/193577
    January 01, 2019 - chemotherapy/ Percentages of relapse and refractory AML. 23/39 had antecedent hematological disorder … Myelofibrosis and Polycythemia Rubra Vera. 23/39 had antecedent hematological disorder
  16. srdr.ahrq.gov/projects/1165/studies/186898
    January 01, 2012 - benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder
  17. srdr.ahrq.gov/projects/published
    December 13, 2021 - nonpharmacological and pharmacological treatments for children and adolescent a confirmed diagnosis of a depressive disorder … (DD)—major depressive disorder (MDD), persistent depressive disorder (PDD, previously termed dysthymia
  18. srdr.ahrq.gov/projects/1165/studies/186946
    January 01, 2009 - benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder
  19. srdr.ahrq.gov/projects/1165/studies/186919
    January 01, 2004 - benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder
  20. srdr.ahrq.gov/projects/1596
    November 22, 2019 - We included trials of Food and Drug Administration (FDA)-approved pharmacotherapies for opioid use disorder … In treatment-seeking populations with opioid use disorder, naltrexone (12 trials; relative risk [RR] … Evidence was lacking on effectiveness of treatments for opioid use disorder related to prescription drug … In treatment-seeking populations with opioid use disorder, naltrexone (12 trials; relative risk [RR] … What are the harms of naloxone in persons with opioid use disorder or misuse?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: